相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic impact of genetic alterations and methylation classes in meningioma
Anna S. Berghoff et al.
BRAIN PATHOLOGY (2022)
Proteogenomic and metabolomic characterization of human glioblastoma
Liang-Bo Wang et al.
CANCER CELL (2021)
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
Queenie Hoi-Wing Wong et al.
MODERN PATHOLOGY (2021)
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
Kenji Fujimoto et al.
ACTA NEUROPATHOLOGICA (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification
Giulia Berzero et al.
NEURO-ONCOLOGY (2021)
Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma
Simone Minasi et al.
CHILDS NERVOUS SYSTEM (2021)
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
Rui Ryan Yang et al.
BRAIN PATHOLOGY (2020)
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
Nayuta Higa et al.
CANCER SCIENCE (2020)
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Sharadha Sakthikumar et al.
GENOME BIOLOGY (2020)
Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
Fan Wu et al.
CARCINOGENESIS (2019)
Doomed from the TERT? A Two-Stage Model of Tumorigenesis in IDH-Wild-Type Glioblastoma
Lucy F. Stead et al.
CANCER CELL (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis
H. G. Vuong et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
IDH mutant astrocytoma: biomarkers for prognostic stratification and the next frontiers
S. Brandner et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
Kosuke Aoki et al.
NEURO-ONCOLOGY (2018)
Pediatric low-grade gliomas can be molecularly stratified for risk
Rui Ryan Yang et al.
ACTA NEUROPATHOLOGICA (2018)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
Reconstructing the molecular life history of gliomas
Floris P. Barthel et al.
ACTA NEUROPATHOLOGICA (2018)
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
Bill H. Diplas et al.
NATURE COMMUNICATIONS (2018)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
Erik A. Williams et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi
Jean-Philippe Fortin et al.
BIOINFORMATICS (2017)
Adult IDH wild-type lower-grade gliomas should be further stratified
Abudumijit Aibaidula et al.
NEURO-ONCOLOGY (2017)
Genomic landscape of high-grade meningiomas
Wenya Linda Bi et al.
NPJ GENOMIC MEDICINE (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Carl Koschmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
Barbara Heidenreich et al.
ONCOTARGET (2015)
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
Matthias Simon et al.
NEURO-ONCOLOGY (2015)
TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi et al.
ACTA NEUROPATHOLOGICA (2013)
Low-level processing of Illumina Infinium DNA Methylation BeadArrays
Timothy J. Triche et al.
NUCLEIC ACIDS RESEARCH (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Roeland F. de Wilde et al.
MODERN PATHOLOGY (2012)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Mechanisms for ATP-dependent chromatin remodelling: the means to the end
Andrew Flaus et al.
FEBS JOURNAL (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
